Royal Melbourne Hospital Joins TRACKER Biobank

---

We are thrilled to announce a significant milestone in the expansion of the TRACKER Biobank! The Royal Melbourne Hospital (RMH), a leading institution renowned for its excellence in healthcare and research, has officially joined TRACKER as a recruitment site. On October 16, 2024, RMH collected its first lung cancer patient sample, marking an important step forward in advancing lung cancer research. 

---

The Significance of RMH’s Contribution

As one of Australia’s premier medical institutions, RMH brings world-class expertise and a deep commitment to advancing cancer care. Its integration into the TRACKER Biobank expands the reach of this important initiative, enabling more patients to contribute to transformative research that has the potential to shape the future of lung cancer treatment. 

The collection of the first patient sample at RMH signifies not only the start of its contribution to TRACKER but also a step closer to new discoveries that will improve the lives of those affected by lung cancer. Every sample collected provides researchers with the resources needed to unravel the complexities of this disease and develop personalised, effective therapies. 

A Collaborative Vision for Better Outcomes

TRACKER is built on the strength of collaboration, and RMH’s participation exemplifies this spirit. Together with our other recruitment sites, researchers, and the patients who make this work possible, we are united in a shared mission to revolutionise lung cancer care. 

We extend our deepest gratitude to the Royal Melbourne Hospital (RMH) and, in particular, to A/Prof Daniel Steinfort, a Respiratory Physician at RMH and Principal Research Fellow at the University of Melbourne, for joining the TRACKER Biobank initiative. A/Prof Steinfort, recognised as a national and international leader in interventional pulmonology, has been instrumental in pioneering and advancing innovative applications of cutting-edge interventional technologies. Under his leadership, RMH's dedicated team brings unparalleled expertise and commitment to this project, driving critical contributions to TRACKER's mission. 

We also thank the patients whose generosity and willingness to participate make this important work possible. This collaboration marks the beginning of an exciting journey, and we eagerly anticipate the impact RMH will have in helping TRACKER realise its vision of a brighter future for lung cancer patients worldwide. 

Stay tuned for more updates as TRACKER continues to grow and advance lung cancer research.